Our March 2020 edition is live!

Our March 2020 issue includes partnering companies focused on developing therapies for oncology.

Go to the profile of Raveena Bhambra
Feb 28, 2020
0
0

Our first issue of the year covers companies focusing on new therapies for the treatment of oncology. The feature editorials cover recent oncology dealmaking trends and a review of the M&As that took place in 2019.

Read the full issue here 

Go to the profile of Raveena Bhambra

Raveena Bhambra

Editor, BioPharma Dealmakers , Nature Research

Hello all, I am the Editor of BioPharma Dealmakers, a quarterly publication that assists companies in identifying potential partners in the pharmaceutical and biotechnology industry and appears in both Nature Biotechnology and Nature Reviews Drug Discovery. I am very passionate about the biopharma industry and have over 15 years of experience of working in the field, specifically in dealmaking, partnering and licensing. In my previous roles I have conducted partner searches identifying both products/technologies and partners for clients, and have edited and written dealmaking-focused reports.

No comments yet.